Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination
Medicinal Research Reviews · 2023-09 · 43 (5) · 1778-1808
DOI: 10.1002/med.21963 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 14.05.2023. Verfasst von Wei Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Alkaloids, Antineoplastic Agents. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 160 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The antitumor efficacy of Chinese herbal medicines has been widely recognized. Leading compounds such as sterols, glycosides, flavonoids, alkaloids, terpenoids, phenylpropanoids, and polyketides constitute their complex active components. The antitumor monomers derived from Chinese medicine possess an attractive anticancer activity. However, their use was limited by low bioavailability, significant toxicity, and side effects, hindering their clinical applications. Recently, new chemical entities have been designed and synthesized by combining natural drugs with other small drug molecules or active moieties to improve the antitumor activity and selectivity, and reduce side effects. Such a novel conjugated drug that can interact with several vital biological targets in cells may have a more significant or synergistic anticancer activity than a single‐molecule drug. In addition, antitumor conjugates could be obtained by combining pharmacophores containing two or more known drugs or leading compounds. Based on these studies, the new drug research and development could be greatly shortened. This study reviews the research progress of conjugates with antitumor activity based on Chinese herbal medicine. It is expected to serve as a valuable reference to antitumor drug research and clinical application of traditional Chinese medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
- Hubei Key Laboratory of Industrial Microbiology, Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei University of Technol…
- Jinan Zhensheng School, Jinan, China.
- Jinan Intellectual Property Protection Center, Jinan, China.
- State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
ORCID-Profile: Ya-Jie Tang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhao, W., Zheng, X. D., Tang, P. Y., Li, H. M., Liu, X., Zhong, J. J., & Tang, Y. J. (2023). Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination. Medicinal Research Reviews, 43(5), 1778-1808. https://doi.org/10.1002/med.21963
Vancouver
Zhao W, Zheng XD, Tang PY, Li HM, Liu X, Zhong JJ, et al. Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination. Medicinal Research Reviews. 2023;43(5):1778-1808. doi:10.1002/med.21963
BibTeX
@article{Zhao2023,
author = {Zhao, Wei and Zheng, Xiao-Di and Tang, Paula Yun-Zhi and Li, Hong-Mei and Liu, Xue and Zhong, Jian-Jiang and Tang, Ya-Jie},
title = {Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination},
journal = {Medicinal Research Reviews},
year = {2023},
volume = {43},
number = {5},
pages = {1778--1808},
doi = {10.1002/med.21963}
}
EUVIMED